Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease.
about
Macrophage-tropic variants initiate human immunodeficiency virus type 1 infection after sexual, parenteral, and vertical transmissionPathogenesis of human immunodeficiency virus infectionGender differences in HIV-1 diversity at time of infectionThe Antibody Response against HIV-1Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantationDifferences in the Selection Bottleneck between Modes of Sexual Transmission Influence the Genetic Composition of the HIV-1 Founder VirusConvergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progressionPopulation genetic estimation of the loss of genetic diversity during horizontal transmission of HIV-1.Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression.AIDS-like disease following mucosal infection of pig-tailed macaques with SIVsmmPBj14.V3 loop sequence space analysis suggests different evolutionary patterns of CCR5- and CXCR4-tropic HIV.Identification of inflections in T-cell counts among HIV-1-infected individuals and relationship with progression to clinical AIDSHost-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution.Methods for subtyping and molecular comparison of human viral genomes.Passive immunotherapy for retroviral disease: influence of major histocompatibility complex type and T-cell responsiveness.Human immunodeficiency virus type 1 populations in blood and semen.Maintenance of an intact human immunodeficiency virus type 1 vpr gene following mother-to-infant transmissionEvolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection.Genetic variation in a human immunodeficiency virus type 2 live-virus Macaca nemestrina vaccine model.Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1.Neuronal death induced by brain-derived human immunodeficiency virus type 1 envelope genes differs between demented and nondemented AIDS patientsA group of V3 sequences from human immunodeficiency virus type 1 subtype E non-syncytium-inducing, CCR5-using variants are resistant to positive selection pressureVariants from the diverse virus population identified at seroconversion of a clade A human immunodeficiency virus type 1-infected woman have distinct biological properties.Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infectionPopulation genetic analysis of the protease locus of human immunodeficiency virus type 1 quasispecies undergoing drug selection, using a denaturing gradient-heteroduplex tracking assay.Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccinesPrimary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity.Timing and order of transmission events is not directly reflected in a pathogen phylogeny.Conservation of an intact vif gene of human immunodeficiency virus type 1 during maternal-fetal transmission.Significance of HIV-1 genetic subtypes.Compartmentalization of surface envelope glycoprotein of human immunodeficiency virus type 1 during acute and chronic infection.Intrapatient diversity and its correlation with viral setpoint in human immunodeficiency virus type 1 CRF02_A/G-IbNG infection.HIV-1 subtype C envelope characteristics associated with divergent rates of chronic disease progressionHuman immunodeficiency virus type 1 superinfection was not detected following 215 years of injection drug user exposure.HIV-1 clade B pol evolution following primary infection.Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cellsCompartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection.Pathogenesis of SIV encephalitis. Selection and replication of neurovirulent SIV
P2860
Q22241902-FDE5AA63-F6F9-44C7-8687-5E9B9B50AE0CQ24634681-9EDD868D-9ACD-455A-845E-0EB9AB3BB432Q24706473-0C8C9703-F663-429C-BD63-06A8757C0BFAQ27000889-08BE4B5F-9FA7-4AC0-99A5-B25E3DFA4D8CQ27485985-8D970C2B-A5CB-44C4-B46A-B26E768F1630Q28551914-BADBB710-D79C-4AFA-A45C-DBC3A66C7D27Q30416671-FDC2C300-4963-4AD0-8EA2-5712287DAF7FQ33237376-B435876F-D522-4F8A-AE7E-A1014E5B6FF4Q33392723-41CB0B3B-32B0-4E9B-96AF-962DF717BE43Q33496573-0DD9BAE9-739F-482B-8F0C-694F4524E2D8Q33509526-0E796AD4-37EB-4DB3-BBBF-82150F2F7BC9Q33558553-0C2A3DB5-237F-4FB8-8027-46126D6DCCAEQ33646567-1E85D770-29B3-466C-9CE0-6EB88AE90CF1Q33749129-4C284FEA-D0A9-4A90-8A0E-3350E1E98F09Q33778686-EE7EB84D-2317-424A-9C6F-7154C36ED310Q33782102-B0A1F612-3D86-4FB1-9CBF-141B0236689FQ33783699-DCAE4A8B-396D-4BB0-A0BF-3C9BD9D8299EQ33784321-DCDE1ED3-0174-4B0C-9E61-2EDFED6B4C6EQ33784708-BA93E4F4-E88C-43FA-B8F9-9B9DB5FC1359Q33784911-168B1E3E-110F-4BD6-A15F-C97624FAB445Q33785357-BDE0F2CE-02BF-4D2D-A238-03A71CFB886FQ33792878-74214F48-ED39-4CA4-94F0-C4021A82BFC3Q33814773-42331647-3B11-4123-9EFA-BBB3BE64B34FQ33825654-D65140E5-6384-46D3-ACAA-D9D5F2BEB3CDQ33843999-AC0275A0-B5A1-416D-B09D-20354ED15940Q33883813-6FA01878-E581-44C6-A546-5A1E8B89E76AQ33911935-7CF682F7-B4E0-48C0-A39D-36866FFF5F5CQ33957148-A6E6C442-C7EC-40C8-8EBB-7ED6157DAA0EQ34005516-F90A81B8-CE7E-4853-AAF1-001234A624CDQ34064859-1E18F8D0-9D1F-4EAA-A384-F26155AD6F18Q34069296-9C961CCA-67D5-43F7-8878-D2F634BC9FE7Q34072534-8F953702-45E2-48CA-8D7D-FEC922EA1C62Q34344788-57E53950-763F-4BAA-A418-375DF42F8BA6Q34349322-140B814B-3C03-4939-8717-1FA6D35CD0EFQ34350944-D1192FB2-B017-4DAC-9092-9BC4C4137338Q34553124-559ED9BA-54DE-462E-8ED7-B77E8EA8A753Q34808574-D6B9884E-C380-4DB2-A982-CA7CAA71754EQ35634313-AD53483E-850C-429D-8C96-BA9A598C02D9Q35704022-49D38BE7-F41A-4B70-8D5E-C87B53ED7983Q35763459-3E1EA3EC-1824-4B2A-8D51-C706DA0A218E
P2860
Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Relationship of human immunode ...... rogeneity to stage of disease.
@en
Relationship of human immunode ...... rogeneity to stage of disease.
@nl
type
label
Relationship of human immunode ...... rogeneity to stage of disease.
@en
Relationship of human immunode ...... rogeneity to stage of disease.
@nl
prefLabel
Relationship of human immunode ...... rogeneity to stage of disease.
@en
Relationship of human immunode ...... rogeneity to stage of disease.
@nl
P2093
P2860
P356
P1476
Relationship of human immunode ...... rogeneity to stage of disease.
@en
P2093
Birdwell A
Hornickova Z
McNearney T
P2860
P304
10247-10251
P356
10.1073/PNAS.89.21.10247
P407
P577
1992-11-01T00:00:00Z